LILRB1 and neoplasm: Last but not least, despite some IRs such as TIM3 and ILT2 are recognized targets for checkpoint blockade (2), they are widely expressed on immune and even tumor cells and the neat contribution of pDC exhaustion in tumor growth and the actual therapeutic significance of pDC rescue via IR blockade remains difficult to assess.